| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 45 | 2025 | 154 | 5.920 |
Why?
|
| Chagas Disease | 32 | 2025 | 101 | 4.560 |
Why?
|
| Protozoan Proteins | 21 | 2022 | 196 | 2.910 |
Why?
|
| Glycoproteins | 10 | 2023 | 127 | 1.450 |
Why?
|
| Leishmaniasis, Cutaneous | 5 | 2023 | 18 | 1.380 |
Why?
|
| Mucins | 6 | 2022 | 69 | 1.060 |
Why?
|
| Leishmania braziliensis | 2 | 2023 | 4 | 1.000 |
Why?
|
| Animals | 85 | 2025 | 16695 | 0.910 |
Why?
|
| Nitroimidazoles | 6 | 2023 | 10 | 0.910 |
Why?
|
| Proteomics | 18 | 2024 | 363 | 0.870 |
Why?
|
| Trypanocidal Agents | 5 | 2023 | 39 | 0.820 |
Why?
|
| Antigens, Protozoan | 7 | 2016 | 74 | 0.800 |
Why?
|
| Polysaccharides | 8 | 2022 | 70 | 0.780 |
Why?
|
| Toll-Like Receptor 2 | 8 | 2020 | 29 | 0.680 |
Why?
|
| Proteome | 8 | 2016 | 150 | 0.670 |
Why?
|
| Fungal Proteins | 8 | 2014 | 143 | 0.660 |
Why?
|
| Rhodnius | 6 | 2011 | 6 | 0.660 |
Why?
|
| Paracoccidioides | 7 | 2013 | 7 | 0.640 |
Why?
|
| Lysophosphatidylcholines | 3 | 2014 | 22 | 0.620 |
Why?
|
| Glycosylphosphatidylinositols | 8 | 2013 | 19 | 0.610 |
Why?
|
| Protozoan Vaccines | 3 | 2015 | 16 | 0.600 |
Why?
|
| Virulence Factors | 4 | 2022 | 119 | 0.590 |
Why?
|
| Mice | 38 | 2024 | 6490 | 0.590 |
Why?
|
| Benzophenanthridines | 1 | 2017 | 11 | 0.560 |
Why?
|
| Insect Vectors | 6 | 2011 | 26 | 0.550 |
Why?
|
| Isoquinolines | 1 | 2017 | 50 | 0.540 |
Why?
|
| Life Cycle Stages | 4 | 2017 | 30 | 0.540 |
Why?
|
| Recombinant Proteins | 5 | 2015 | 522 | 0.530 |
Why?
|
| Flagella | 4 | 2017 | 31 | 0.530 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 12 | 2019 | 456 | 0.530 |
Why?
|
| Humans | 67 | 2025 | 42163 | 0.530 |
Why?
|
| Immunologic Factors | 2 | 2014 | 50 | 0.510 |
Why?
|
| Platelet Activating Factor | 2 | 2014 | 9 | 0.510 |
Why?
|
| Glycomics | 3 | 2012 | 8 | 0.490 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 134 | 0.490 |
Why?
|
| Secretory Vesicles | 5 | 2014 | 21 | 0.480 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 287 | 0.460 |
Why?
|
| Trisaccharides | 6 | 2023 | 11 | 0.460 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2023 | 8 | 0.460 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2023 | 82 | 0.450 |
Why?
|
| Lipids | 8 | 2023 | 256 | 0.430 |
Why?
|
| Salivary Glands | 3 | 2023 | 12 | 0.430 |
Why?
|
| Cell Membrane | 2 | 2013 | 400 | 0.420 |
Why?
|
| Cystatins | 1 | 2013 | 19 | 0.410 |
Why?
|
| Mass Spectrometry | 12 | 2016 | 279 | 0.400 |
Why?
|
| Triazoles | 3 | 2021 | 100 | 0.400 |
Why?
|
| Cell Wall | 5 | 2015 | 55 | 0.400 |
Why?
|
| Antibodies, Protozoan | 7 | 2016 | 82 | 0.390 |
Why?
|
| Francisella tularensis | 1 | 2013 | 116 | 0.380 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2011 | 9 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 415 | 0.370 |
Why?
|
| Wasp Venoms | 1 | 2011 | 6 | 0.360 |
Why?
|
| Epitopes | 7 | 2018 | 155 | 0.340 |
Why?
|
| Water Pollutants, Chemical | 2 | 2025 | 170 | 0.340 |
Why?
|
| Molecular Sequence Data | 17 | 2015 | 1559 | 0.330 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2019 | 230 | 0.330 |
Why?
|
| Lipid Metabolism | 4 | 2023 | 140 | 0.330 |
Why?
|
| Giardia lamblia | 3 | 2019 | 32 | 0.330 |
Why?
|
| NF-kappa B | 5 | 2020 | 355 | 0.320 |
Why?
|
| Toxoplasma | 1 | 2019 | 12 | 0.320 |
Why?
|
| Dimerization | 1 | 2019 | 115 | 0.310 |
Why?
|
| DNA, Protozoan | 2 | 2025 | 27 | 0.310 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 84 | 0.300 |
Why?
|
| Paracoccidioidomycosis | 3 | 2014 | 4 | 0.300 |
Why?
|
| Membrane Glycoproteins | 7 | 2023 | 221 | 0.300 |
Why?
|
| Amino Acid Sequence | 13 | 2015 | 1188 | 0.300 |
Why?
|
| Cryptococcus neoformans | 4 | 2015 | 62 | 0.300 |
Why?
|
| Micronucleus Tests | 4 | 2023 | 16 | 0.290 |
Why?
|
| Macrophages | 11 | 2020 | 515 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 1804 | 0.290 |
Why?
|
| Heme | 4 | 2015 | 72 | 0.290 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 12 | 2015 | 140 | 0.290 |
Why?
|
| Candida albicans | 3 | 2022 | 173 | 0.280 |
Why?
|
| Treatment Outcome | 6 | 2021 | 1586 | 0.280 |
Why?
|
| Phosphoproteins | 1 | 2009 | 201 | 0.280 |
Why?
|
| Signal Transduction | 9 | 2019 | 2111 | 0.270 |
Why?
|
| Platelet Aggregation | 3 | 2018 | 21 | 0.270 |
Why?
|
| Bolivia | 3 | 2021 | 9 | 0.270 |
Why?
|
| Serologic Tests | 2 | 2022 | 45 | 0.260 |
Why?
|
| Plasma | 2 | 2020 | 38 | 0.260 |
Why?
|
| Transport Vesicles | 3 | 2014 | 22 | 0.260 |
Why?
|
| Fatty Acid Desaturases | 1 | 2006 | 4 | 0.260 |
Why?
|
| Reticulocytes | 2 | 2020 | 9 | 0.260 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1679 | 0.260 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2006 | 8 | 0.260 |
Why?
|
| Cell Line | 6 | 2019 | 1416 | 0.260 |
Why?
|
| Leishmania major | 4 | 2018 | 23 | 0.250 |
Why?
|
| Brazil | 7 | 2025 | 83 | 0.250 |
Why?
|
| Chromatography, Liquid | 4 | 2013 | 173 | 0.250 |
Why?
|
| Phospholipids | 4 | 2012 | 69 | 0.240 |
Why?
|
| Environmental Monitoring | 2 | 2025 | 226 | 0.240 |
Why?
|
| Parasites | 2 | 2023 | 36 | 0.240 |
Why?
|
| Models, Molecular | 4 | 2019 | 875 | 0.230 |
Why?
|
| Giardiasis | 2 | 2022 | 13 | 0.230 |
Why?
|
| Rivers | 1 | 2025 | 50 | 0.230 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2025 | 25 | 0.230 |
Why?
|
| Macrophages, Peritoneal | 3 | 2013 | 23 | 0.220 |
Why?
|
| Lymphocytes | 3 | 2023 | 124 | 0.220 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 3 | 0.220 |
Why?
|
| Virulence | 5 | 2013 | 238 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 358 | 0.210 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2019 | 102 | 0.210 |
Why?
|
| Exocytosis | 3 | 2013 | 49 | 0.210 |
Why?
|
| Trypanosomiasis, African | 2 | 2016 | 22 | 0.210 |
Why?
|
| Female | 20 | 2024 | 24018 | 0.200 |
Why?
|
| Micronuclei, Chromosome-Defective | 2 | 2020 | 7 | 0.200 |
Why?
|
| Pentoxifylline | 1 | 2023 | 6 | 0.200 |
Why?
|
| Trypanosoma | 1 | 2023 | 8 | 0.200 |
Why?
|
| Agaricales | 1 | 2023 | 8 | 0.200 |
Why?
|
| Plant Proteins | 3 | 2015 | 100 | 0.200 |
Why?
|
| Reishi | 1 | 2023 | 10 | 0.200 |
Why?
|
| Microscopy, Electron, Transmission | 6 | 2014 | 160 | 0.190 |
Why?
|
| Cysts | 1 | 2022 | 10 | 0.190 |
Why?
|
| Pesticides | 1 | 2023 | 59 | 0.190 |
Why?
|
| Cytokines | 8 | 2019 | 661 | 0.190 |
Why?
|
| Insect Proteins | 3 | 2011 | 51 | 0.190 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 77 | 0.190 |
Why?
|
| RNA, Protozoan | 2 | 2014 | 13 | 0.190 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2021 | 14 | 0.190 |
Why?
|
| Histoplasma | 3 | 2012 | 6 | 0.180 |
Why?
|
| Biological Assay | 2 | 2020 | 63 | 0.180 |
Why?
|
| Carica | 2 | 2012 | 6 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 6 | 2014 | 686 | 0.180 |
Why?
|
| Membrane Microdomains | 2 | 2022 | 53 | 0.180 |
Why?
|
| Saliva | 2 | 2016 | 115 | 0.180 |
Why?
|
| Cells, Cultured | 7 | 2020 | 1617 | 0.180 |
Why?
|
| Plant Diseases | 2 | 2012 | 61 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1112 | 0.170 |
Why?
|
| Cichlids | 1 | 2020 | 5 | 0.170 |
Why?
|
| Biological Transport | 5 | 2013 | 201 | 0.170 |
Why?
|
| Tilapia | 1 | 2020 | 10 | 0.170 |
Why?
|
| Sphingolipids | 2 | 2013 | 14 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 206 | 0.170 |
Why?
|
| Spleen | 2 | 2020 | 199 | 0.170 |
Why?
|
| Toll-Like Receptors | 5 | 2014 | 51 | 0.170 |
Why?
|
| Mouth Mucosa | 1 | 2020 | 30 | 0.170 |
Why?
|
| Plasmodium vivax | 1 | 2020 | 8 | 0.170 |
Why?
|
| Blood Proteins | 2 | 2013 | 75 | 0.170 |
Why?
|
| Polyvinyl Chloride | 1 | 2020 | 4 | 0.170 |
Why?
|
| Laboratories | 1 | 2020 | 40 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 16 | 0.170 |
Why?
|
| Onions | 1 | 2020 | 11 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 2020 | 237 | 0.160 |
Why?
|
| Drug Monitoring | 1 | 2020 | 20 | 0.160 |
Why?
|
| Heart Transplantation | 1 | 2020 | 47 | 0.160 |
Why?
|
| Peptides | 3 | 2009 | 357 | 0.160 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 62 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 51 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2021 | 1574 | 0.160 |
Why?
|
| Molecular Structure | 4 | 2017 | 560 | 0.160 |
Why?
|
| Cell Survival | 3 | 2017 | 934 | 0.160 |
Why?
|
| Trophozoites | 1 | 2019 | 8 | 0.160 |
Why?
|
| Sphingomyelins | 1 | 2019 | 9 | 0.160 |
Why?
|
| Mitochondria, Liver | 2 | 2009 | 15 | 0.160 |
Why?
|
| Host-Parasite Interactions | 4 | 2020 | 75 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2020 | 426 | 0.160 |
Why?
|
| Nitric Oxide | 5 | 2014 | 381 | 0.160 |
Why?
|
| Macrophage Activation | 3 | 2012 | 59 | 0.150 |
Why?
|
| Sterols | 2 | 2017 | 23 | 0.150 |
Why?
|
| Tsetse Flies | 2 | 2017 | 8 | 0.150 |
Why?
|
| Ceramides | 1 | 2019 | 43 | 0.150 |
Why?
|
| Male | 18 | 2024 | 22779 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 71 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2013 | 64 | 0.150 |
Why?
|
| Nitric Oxide Synthase | 2 | 2009 | 134 | 0.150 |
Why?
|
| Rabbits | 4 | 2014 | 292 | 0.150 |
Why?
|
| Glycolipids | 2 | 2009 | 9 | 0.150 |
Why?
|
| Epitope Mapping | 3 | 2016 | 31 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2023 | 548 | 0.150 |
Why?
|
| Fibroblasts | 1 | 2020 | 278 | 0.150 |
Why?
|
| Cell Nucleus | 1 | 2020 | 383 | 0.150 |
Why?
|
| Macaca mulatta | 1 | 2019 | 139 | 0.140 |
Why?
|
| Antibodies, Helminth | 1 | 2018 | 24 | 0.140 |
Why?
|
| Antigens, Helminth | 1 | 2018 | 34 | 0.140 |
Why?
|
| Adult | 8 | 2021 | 13458 | 0.140 |
Why?
|
| Papaveraceae | 1 | 2017 | 1 | 0.140 |
Why?
|
| Sanguinaria | 1 | 2017 | 1 | 0.140 |
Why?
|
| Endocytosis | 2 | 2015 | 117 | 0.140 |
Why?
|
| Leishmaniasis Vaccines | 1 | 2017 | 8 | 0.140 |
Why?
|
| Galactosides | 1 | 2017 | 11 | 0.140 |
Why?
|
| Blood Platelets | 1 | 2018 | 80 | 0.140 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2022 | 199 | 0.140 |
Why?
|
| Thrombosis | 1 | 2018 | 81 | 0.140 |
Why?
|
| Kidney | 3 | 2023 | 363 | 0.140 |
Why?
|
| Lectins | 2 | 2014 | 19 | 0.140 |
Why?
|
| Gentisates | 1 | 2017 | 2 | 0.140 |
Why?
|
| Cell-Derived Microparticles | 2 | 2020 | 8 | 0.140 |
Why?
|
| Antimutagenic Agents | 1 | 2017 | 2 | 0.140 |
Why?
|
| Oogenesis | 2 | 2008 | 29 | 0.140 |
Why?
|
| Thiazoles | 1 | 2018 | 76 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 147 | 0.130 |
Why?
|
| Antigens, Surface | 2 | 2011 | 50 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 491 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 501 | 0.130 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1554 | 0.130 |
Why?
|
| Sequence Alignment | 5 | 2011 | 273 | 0.130 |
Why?
|
| Time Factors | 5 | 2018 | 1848 | 0.130 |
Why?
|
| Epitopes, B-Lymphocyte | 3 | 2014 | 12 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2017 | 79 | 0.130 |
Why?
|
| Double-Blind Method | 3 | 2021 | 305 | 0.130 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2016 | 11 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 506 | 0.130 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2007 | 10 | 0.130 |
Why?
|
| Mutagens | 1 | 2017 | 76 | 0.130 |
Why?
|
| Receptors, Cell Surface | 4 | 2004 | 146 | 0.130 |
Why?
|
| Blotting, Western | 8 | 2013 | 884 | 0.130 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 49 | 0.130 |
Why?
|
| Hemocytes | 2 | 2006 | 11 | 0.130 |
Why?
|
| Acyltransferases | 1 | 2016 | 21 | 0.120 |
Why?
|
| Cholesterol | 3 | 2017 | 230 | 0.120 |
Why?
|
| Food Hypersensitivity | 1 | 2016 | 5 | 0.120 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2016 | 6 | 0.120 |
Why?
|
| Ticks | 1 | 2016 | 8 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2023 | 683 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1420 | 0.120 |
Why?
|
| Antiprotozoal Agents | 1 | 2016 | 33 | 0.120 |
Why?
|
| Killer Cells, Natural | 2 | 2009 | 99 | 0.120 |
Why?
|
| Cerium | 1 | 2015 | 18 | 0.120 |
Why?
|
| Rhipicephalus | 1 | 2015 | 5 | 0.120 |
Why?
|
| Metals | 1 | 2016 | 113 | 0.120 |
Why?
|
| Oligosaccharides | 1 | 2015 | 28 | 0.120 |
Why?
|
| Phaseolus | 1 | 2015 | 20 | 0.120 |
Why?
|
| Seeds | 1 | 2015 | 46 | 0.120 |
Why?
|
| Receptors, Peptide | 1 | 2015 | 24 | 0.120 |
Why?
|
| Protein Transport | 3 | 2013 | 295 | 0.120 |
Why?
|
| Intestines | 1 | 2015 | 71 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 2015 | 50 | 0.110 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2014 | 12 | 0.110 |
Why?
|
| Extracellular Space | 2 | 2014 | 36 | 0.110 |
Why?
|
| Cysteine | 1 | 2015 | 101 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 83 | 0.110 |
Why?
|
| Leishmania | 1 | 2014 | 19 | 0.110 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2014 | 4 | 0.110 |
Why?
|
| Insecticide Resistance | 2 | 2011 | 14 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2012 | 36 | 0.110 |
Why?
|
| Ixodidae | 2 | 2005 | 8 | 0.110 |
Why?
|
| Disulfides | 1 | 2015 | 92 | 0.110 |
Why?
|
| Fatty Acids | 3 | 2023 | 134 | 0.110 |
Why?
|
| Liposomes | 1 | 2015 | 130 | 0.110 |
Why?
|
| Azepines | 1 | 2014 | 22 | 0.110 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2012 | 35 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 144 | 0.110 |
Why?
|
| Toll-Like Receptor 1 | 2 | 2019 | 3 | 0.110 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2019 | 3 | 0.110 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 7 | 0.110 |
Why?
|
| Protein Binding | 5 | 2015 | 1076 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2011 | 77 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 457 | 0.110 |
Why?
|
| Chromatography, Thin Layer | 5 | 2014 | 39 | 0.100 |
Why?
|
| Antigens, Fungal | 3 | 2014 | 33 | 0.100 |
Why?
|
| Galactose | 1 | 2013 | 9 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 2 | 2014 | 214 | 0.100 |
Why?
|
| Macrophages, Alveolar | 1 | 2013 | 33 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 88 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 105 | 0.100 |
Why?
|
| Child | 1 | 2021 | 3381 | 0.100 |
Why?
|
| Mitosporic Fungi | 1 | 2013 | 5 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2015 | 458 | 0.100 |
Why?
|
| Glycosyltransferases | 1 | 2013 | 9 | 0.100 |
Why?
|
| Subcellular Fractions | 2 | 2013 | 79 | 0.100 |
Why?
|
| Lysosomes | 1 | 2013 | 88 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2013 | 83 | 0.100 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 33 | 0.100 |
Why?
|
| Ultracentrifugation | 1 | 2013 | 14 | 0.100 |
Why?
|
| Cerebrosides | 3 | 2012 | 3 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2012 | 301 | 0.100 |
Why?
|
| Mycoses | 1 | 2013 | 31 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 136 | 0.100 |
Why?
|
| Mucin-1 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Tularemia | 1 | 2013 | 115 | 0.100 |
Why?
|
| Glycopeptides | 1 | 2012 | 14 | 0.100 |
Why?
|
| Computational Biology | 2 | 2012 | 324 | 0.100 |
Why?
|
| Autoantigens | 1 | 2013 | 85 | 0.100 |
Why?
|
| Genome, Protozoan | 2 | 2009 | 13 | 0.100 |
Why?
|
| Organelles | 2 | 2010 | 21 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 64 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2017 | 1010 | 0.100 |
Why?
|
| Plant Viruses | 1 | 2012 | 7 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 4936 | 0.090 |
Why?
|
| Proteins | 1 | 2015 | 383 | 0.090 |
Why?
|
| Renin | 1 | 2012 | 31 | 0.090 |
Why?
|
| Models, Immunological | 1 | 2011 | 21 | 0.090 |
Why?
|
| Plasmodium yoelii | 1 | 2011 | 10 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2011 | 31 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 5 | 2015 | 254 | 0.090 |
Why?
|
| Lipocalins | 1 | 2011 | 6 | 0.090 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2011 | 15 | 0.090 |
Why?
|
| Inclusion Bodies | 1 | 2011 | 34 | 0.090 |
Why?
|
| Panstrongylus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Glycoconjugates | 1 | 2011 | 6 | 0.090 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2011 | 5 | 0.090 |
Why?
|
| Adolescent | 5 | 2020 | 5950 | 0.090 |
Why?
|
| Enzymes | 1 | 2011 | 34 | 0.090 |
Why?
|
| Smoking | 1 | 2018 | 1019 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2011 | 49 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 32 | 0.090 |
Why?
|
| Snails | 1 | 2011 | 32 | 0.090 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 90 | 0.090 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 17 | 0.090 |
Why?
|
| Heat-Shock Response | 1 | 2011 | 22 | 0.090 |
Why?
|
| Malaria | 1 | 2011 | 90 | 0.080 |
Why?
|
| Biliverdine | 2 | 2007 | 8 | 0.080 |
Why?
|
| Cryptococcus gattii | 1 | 2010 | 8 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2013 | 82 | 0.080 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 183 | 0.080 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2010 | 17 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 126 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 427 | 0.080 |
Why?
|
| Immunity, Innate | 4 | 2006 | 168 | 0.080 |
Why?
|
| Melanoma, Experimental | 1 | 2009 | 13 | 0.080 |
Why?
|
| Arginase | 1 | 2009 | 14 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 2 | 2007 | 64 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 135 | 0.080 |
Why?
|
| Exosomes | 1 | 2011 | 124 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2019 | 21 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 1058 | 0.080 |
Why?
|
| Cell Movement | 1 | 2013 | 640 | 0.080 |
Why?
|
| Detergents | 1 | 2009 | 25 | 0.080 |
Why?
|
| Mice, Inbred C3H | 4 | 2014 | 80 | 0.080 |
Why?
|
| Phosphoserine | 1 | 2009 | 21 | 0.080 |
Why?
|
| Endopeptidase K | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2009 | 12 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 94 | 0.080 |
Why?
|
| Trypsin | 1 | 2009 | 40 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2011 | 404 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 223 | 0.080 |
Why?
|
| Polystyrenes | 1 | 2009 | 20 | 0.080 |
Why?
|
| Aspergillus niger | 1 | 2008 | 1 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2009 | 111 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 1051 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 188 | 0.070 |
Why?
|
| Blood Banks | 1 | 2008 | 10 | 0.070 |
Why?
|
| Adaptation, Biological | 1 | 2008 | 28 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 436 | 0.070 |
Why?
|
| Protein Carbonylation | 1 | 2008 | 8 | 0.070 |
Why?
|
| Rats | 6 | 2017 | 3701 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 318 | 0.070 |
Why?
|
| Middle Aged | 6 | 2022 | 11819 | 0.070 |
Why?
|
| Ovary | 1 | 2008 | 112 | 0.070 |
Why?
|
| Tyrosine | 1 | 2008 | 119 | 0.070 |
Why?
|
| Cytokinesis | 1 | 2008 | 10 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 94 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 77 | 0.070 |
Why?
|
| Mutation | 4 | 2015 | 1169 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2011 | 461 | 0.070 |
Why?
|
| Comet Assay | 2 | 2023 | 77 | 0.070 |
Why?
|
| Cryptococcosis | 1 | 2007 | 43 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 22 | 0.070 |
Why?
|
| Galactosyltransferases | 2 | 2017 | 6 | 0.070 |
Why?
|
| Cricetinae | 3 | 2020 | 241 | 0.070 |
Why?
|
| Spiders | 1 | 2006 | 9 | 0.070 |
Why?
|
| Kinins | 1 | 2006 | 3 | 0.070 |
Why?
|
| Glycosaminoglycans | 2 | 2020 | 24 | 0.070 |
Why?
|
| Base Sequence | 2 | 2006 | 997 | 0.070 |
Why?
|
| Trypanosomatina | 1 | 2006 | 4 | 0.060 |
Why?
|
| Spermidine | 1 | 2006 | 34 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 48 | 0.060 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2006 | 13 | 0.060 |
Why?
|
| Restriction Mapping | 1 | 2006 | 45 | 0.060 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2006 | 27 | 0.060 |
Why?
|
| Aedes | 1 | 2007 | 42 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2006 | 34 | 0.060 |
Why?
|
| Sequence Analysis | 1 | 2006 | 26 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2006 | 68 | 0.060 |
Why?
|
| Trypanosoma congolense | 1 | 2006 | 3 | 0.060 |
Why?
|
| Flight, Animal | 1 | 2006 | 5 | 0.060 |
Why?
|
| RNA Interference | 3 | 2015 | 246 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2006 | 149 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 448 | 0.060 |
Why?
|
| Phylogeny | 2 | 2009 | 740 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 158 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2006 | 68 | 0.060 |
Why?
|
| Pyridines | 1 | 2007 | 134 | 0.060 |
Why?
|
| Glycosphingolipids | 2 | 2003 | 5 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 602 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 211 | 0.060 |
Why?
|
| Anticoagulants | 2 | 2020 | 121 | 0.060 |
Why?
|
| Ascomycota | 1 | 2005 | 21 | 0.060 |
Why?
|
| Ecotoxicology | 1 | 2025 | 10 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2022 | 541 | 0.060 |
Why?
|
| Plants | 1 | 2006 | 114 | 0.060 |
Why?
|
| Interleukin-12 | 3 | 2014 | 46 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 78 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2005 | 37 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2005 | 25 | 0.060 |
Why?
|
| Hypertension | 1 | 2012 | 823 | 0.060 |
Why?
|
| Sugar Phosphates | 1 | 2004 | 4 | 0.060 |
Why?
|
| Erythritol | 1 | 2004 | 4 | 0.060 |
Why?
|
| Fosfomycin | 1 | 2004 | 5 | 0.060 |
Why?
|
| Pyridoxal Phosphate | 1 | 2004 | 11 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 74 | 0.060 |
Why?
|
| Nasopharyngeal Diseases | 1 | 2004 | 1 | 0.060 |
Why?
|
| Ear Diseases | 1 | 2004 | 2 | 0.060 |
Why?
|
| Coxiella burnetii | 1 | 2004 | 16 | 0.060 |
Why?
|
| Adolescent Health Services | 1 | 2004 | 29 | 0.060 |
Why?
|
| Pneumococcal Vaccines | 1 | 2004 | 16 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 518 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2004 | 44 | 0.050 |
Why?
|
| Colletotrichum | 1 | 2004 | 1 | 0.050 |
Why?
|
| Glucosylceramides | 1 | 2004 | 3 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2004 | 34 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2004 | 33 | 0.050 |
Why?
|
| Dendritic Cells | 3 | 2014 | 130 | 0.050 |
Why?
|
| Brucella abortus | 1 | 2004 | 4 | 0.050 |
Why?
|
| Brucellosis | 1 | 2004 | 8 | 0.050 |
Why?
|
| Citrates | 1 | 2023 | 20 | 0.050 |
Why?
|
| Mannose | 1 | 2023 | 30 | 0.050 |
Why?
|
| Phospholipid Ethers | 1 | 2003 | 4 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 2012 | 301 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2004 | 73 | 0.050 |
Why?
|
| Histones | 1 | 2005 | 194 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 2015 | 121 | 0.050 |
Why?
|
| Cattle | 3 | 2015 | 505 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 55 | 0.050 |
Why?
|
| Alanine | 1 | 2023 | 33 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2015 | 230 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2017 | 167 | 0.050 |
Why?
|
| Plasmodium falciparum | 1 | 2004 | 146 | 0.050 |
Why?
|
| Heterochromatin | 1 | 2023 | 19 | 0.050 |
Why?
|
| Antigens, CD1 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Golgi Apparatus | 2 | 2013 | 28 | 0.050 |
Why?
|
| Oseltamivir | 1 | 2022 | 9 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 928 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2024 | 115 | 0.050 |
Why?
|
| Giardia | 1 | 2022 | 15 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 165 | 0.050 |
Why?
|
| Isomerism | 2 | 2016 | 65 | 0.050 |
Why?
|
| Psychodidae | 1 | 2002 | 3 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 109 | 0.050 |
Why?
|
| Leishmania infantum | 1 | 2002 | 10 | 0.050 |
Why?
|
| Eukaryota | 1 | 2002 | 20 | 0.050 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 235 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 166 | 0.050 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 1 | 2002 | 8 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 91 | 0.050 |
Why?
|
| Hyphae | 1 | 2022 | 36 | 0.050 |
Why?
|
| Species Specificity | 2 | 2013 | 279 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2012 | 206 | 0.050 |
Why?
|
| Homeostasis | 1 | 2023 | 193 | 0.050 |
Why?
|
| Cell Fractionation | 2 | 2013 | 30 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 658 | 0.040 |
Why?
|
| Prognosis | 1 | 2024 | 850 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2009 | 271 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2004 | 429 | 0.040 |
Why?
|
| Chondroitin Sulfates | 1 | 2020 | 11 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 60 | 0.040 |
Why?
|
| Phosphatidylglycerols | 2 | 2012 | 11 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 649 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2598 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2013 | 1265 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 153 | 0.040 |
Why?
|
| Phosphatidylcholines | 2 | 2012 | 35 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 111 | 0.040 |
Why?
|
| Malaria, Vivax | 1 | 2020 | 4 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 233 | 0.040 |
Why?
|
| Erythrocytes | 2 | 2016 | 126 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 203 | 0.040 |
Why?
|
| Parasitemia | 2 | 2011 | 13 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2020 | 58 | 0.040 |
Why?
|
| Neoplasms | 1 | 2011 | 1341 | 0.040 |
Why?
|
| Biofilms | 1 | 2022 | 178 | 0.040 |
Why?
|
| Microvessels | 1 | 2020 | 31 | 0.040 |
Why?
|
| Cricetulus | 1 | 2020 | 82 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 196 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1266 | 0.040 |
Why?
|
| Liver | 1 | 2023 | 503 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2019 | 25 | 0.040 |
Why?
|
| Sphingosine | 1 | 2019 | 22 | 0.040 |
Why?
|
| Cell Death | 1 | 2020 | 277 | 0.040 |
Why?
|
| Hemolymph | 2 | 2011 | 8 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 115 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 193 | 0.040 |
Why?
|
| Inflammation | 1 | 2004 | 729 | 0.040 |
Why?
|
| Binding Sites | 2 | 2015 | 670 | 0.040 |
Why?
|
| Bacteria | 1 | 2002 | 285 | 0.040 |
Why?
|
| Mitochondria | 1 | 2023 | 516 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 184 | 0.040 |
Why?
|
| Lead | 1 | 2020 | 101 | 0.040 |
Why?
|
| Immune Sera | 2 | 2013 | 56 | 0.040 |
Why?
|
| Platelet Function Tests | 1 | 2018 | 7 | 0.040 |
Why?
|
| Antibodies, Fungal | 2 | 2011 | 24 | 0.040 |
Why?
|
| Middle East | 1 | 2018 | 21 | 0.040 |
Why?
|
| Carbohydrate Sequence | 3 | 2002 | 20 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 95 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 28 | 0.040 |
Why?
|
| Placebos | 1 | 2018 | 41 | 0.040 |
Why?
|
| DNA Damage | 1 | 2020 | 358 | 0.040 |
Why?
|
| Serotyping | 2 | 2010 | 37 | 0.030 |
Why?
|
| Gene Expression | 2 | 2015 | 692 | 0.030 |
Why?
|
| Ergosterol | 1 | 2017 | 12 | 0.030 |
Why?
|
| Amphotericin B | 1 | 2017 | 25 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2017 | 35 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 256 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 487 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2013 | 973 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 2006 | 52 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 181 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2016 | 14 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 454 | 0.030 |
Why?
|
| Ions | 1 | 2016 | 71 | 0.030 |
Why?
|
| Viruses | 1 | 2016 | 39 | 0.030 |
Why?
|
| Rhodamines | 1 | 2016 | 23 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2016 | 17 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 59 | 0.030 |
Why?
|
| Acaricides | 1 | 2015 | 1 | 0.030 |
Why?
|
| Toluidines | 1 | 2015 | 3 | 0.030 |
Why?
|
| Rhodamine 123 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 26 | 0.030 |
Why?
|
| Tick Infestations | 1 | 2015 | 4 | 0.030 |
Why?
|
| Anemia | 1 | 2016 | 52 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 276 | 0.030 |
Why?
|
| Nutritive Value | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2015 | 36 | 0.030 |
Why?
|
| Metalloporphyrins | 1 | 2015 | 12 | 0.030 |
Why?
|
| Multigene Family | 1 | 2015 | 105 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2015 | 39 | 0.030 |
Why?
|
| Protoporphyrins | 1 | 2015 | 20 | 0.030 |
Why?
|
| Antibodies | 1 | 2015 | 140 | 0.030 |
Why?
|
| Leishmania tropica | 1 | 2014 | 1 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 2014 | 7 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2008 | 348 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2015 | 108 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 26 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1054 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 168 | 0.030 |
Why?
|
| Lipid A | 2 | 2004 | 8 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 205 | 0.030 |
Why?
|
| Soil Pollutants | 1 | 2015 | 104 | 0.030 |
Why?
|
| CHO Cells | 2 | 2004 | 123 | 0.030 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2013 | 7 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2006 | 300 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 26 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2013 | 6 | 0.030 |
Why?
|
| Gene Library | 1 | 2014 | 60 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2014 | 29 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2014 | 78 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 845 | 0.030 |
Why?
|
| Drug Antagonism | 1 | 2013 | 5 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2014 | 59 | 0.030 |
Why?
|
| Luminescence | 1 | 2013 | 23 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2014 | 86 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 111 | 0.030 |
Why?
|
| Carbohydrate Conformation | 1 | 2013 | 15 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2013 | 20 | 0.030 |
Why?
|
| Vero Cells | 1 | 2013 | 109 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 1737 | 0.030 |
Why?
|
| Genes, Protozoan | 2 | 2004 | 18 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 39 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 98 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 209 | 0.020 |
Why?
|
| Digestive System | 2 | 2003 | 21 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2004 | 411 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2006 | 461 | 0.020 |
Why?
|
| Hela Cells | 1 | 2013 | 370 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 41 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 2012 | 14 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2012 | 21 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 462 | 0.020 |
Why?
|
| Nitrites | 1 | 2012 | 54 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 2012 | 18 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2012 | 20 | 0.020 |
Why?
|
| Angiotensin I | 1 | 2012 | 5 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2012 | 42 | 0.020 |
Why?
|
| Neprilysin | 1 | 2012 | 8 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 22 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 42 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2012 | 44 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2012 | 67 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 303 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2011 | 75 | 0.020 |
Why?
|
| Fluorometry | 1 | 2011 | 17 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 122 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 44 | 0.020 |
Why?
|
| Vertebrates | 1 | 2011 | 33 | 0.020 |
Why?
|
| Immunization | 1 | 2011 | 93 | 0.020 |
Why?
|
| Haplorhini | 1 | 2011 | 23 | 0.020 |
Why?
|
| Triatoma | 1 | 2011 | 4 | 0.020 |
Why?
|
| Oxazines | 1 | 2011 | 32 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2012 | 103 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 67 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 37 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2011 | 41 | 0.020 |
Why?
|
| Galectins | 1 | 2011 | 29 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 37 | 0.020 |
Why?
|
| Collagen | 1 | 2012 | 178 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 164 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 180 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 149 | 0.020 |
Why?
|
| Lipoylation | 1 | 2010 | 17 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 66 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 142 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 128 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 72 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 484 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2011 | 134 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 217 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 154 | 0.020 |
Why?
|
| Genome, Human | 1 | 2011 | 143 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 253 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 310 | 0.020 |
Why?
|
| Hybridomas | 1 | 2009 | 24 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2015 | 449 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2012 | 253 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 3942 | 0.020 |
Why?
|
| Temperature | 1 | 2011 | 314 | 0.020 |
Why?
|
| Octoxynol | 1 | 2009 | 19 | 0.020 |
Why?
|
| Immunochemistry | 1 | 2009 | 9 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2009 | 90 | 0.020 |
Why?
|
| NADP | 1 | 2009 | 37 | 0.020 |
Why?
|
| Citrulline | 1 | 2009 | 14 | 0.020 |
Why?
|
| Zymosan | 1 | 2008 | 1 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 2009 | 17 | 0.020 |
Why?
|
| Calmodulin | 1 | 2009 | 44 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 75 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2009 | 101 | 0.020 |
Why?
|
| Nitrosation | 1 | 2008 | 5 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2008 | 69 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 24 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 28 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 169 | 0.020 |
Why?
|
| Histoplasmosis | 1 | 2008 | 3 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 181 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 662 | 0.020 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2008 | 3 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 534 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2008 | 20 | 0.020 |
Why?
|
| Laccase | 1 | 2007 | 7 | 0.020 |
Why?
|
| Urease | 1 | 2007 | 16 | 0.020 |
Why?
|
| Bile Pigments | 1 | 2007 | 1 | 0.020 |
Why?
|
| Pigments, Biological | 1 | 2007 | 18 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 574 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2007 | 12 | 0.020 |
Why?
|
| Micrococcus luteus | 1 | 2006 | 4 | 0.020 |
Why?
|
| Kininogens | 1 | 2006 | 4 | 0.020 |
Why?
|
| Bradykinin | 1 | 2006 | 23 | 0.020 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2006 | 9 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2002 | 1066 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 85 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2006 | 9 | 0.020 |
Why?
|
| Tritium | 1 | 2006 | 51 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 78 | 0.020 |
Why?
|
| Peptide Library | 1 | 2006 | 27 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2006 | 31 | 0.020 |
Why?
|
| Muscles | 1 | 2006 | 84 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 98 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 198 | 0.020 |
Why?
|
| Myocardium | 1 | 2008 | 251 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 195 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2006 | 112 | 0.020 |
Why?
|
| Catalysis | 1 | 2006 | 191 | 0.010 |
Why?
|
| Dengue | 1 | 2007 | 100 | 0.010 |
Why?
|
| Porphyrins | 1 | 2006 | 57 | 0.010 |
Why?
|
| Melanins | 1 | 2005 | 42 | 0.010 |
Why?
|
| Skin | 1 | 2006 | 185 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 2005 | 14 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2005 | 20 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2006 | 205 | 0.010 |
Why?
|
| Pentosephosphates | 1 | 2004 | 4 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 32 | 0.010 |
Why?
|
| Ear, Middle | 1 | 2004 | 2 | 0.010 |
Why?
|
| Ubiquinone | 1 | 2004 | 22 | 0.010 |
Why?
|
| Mycelium | 1 | 2004 | 5 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 2004 | 21 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2004 | 47 | 0.010 |
Why?
|
| Antimalarials | 1 | 2004 | 63 | 0.010 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2003 | 15 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 117 | 0.010 |
Why?
|
| Malaria, Falciparum | 1 | 2004 | 91 | 0.010 |
Why?
|
| Digestion | 1 | 2003 | 14 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 92 | 0.010 |
Why?
|
| Blood | 1 | 2003 | 37 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 633 | 0.010 |
Why?
|
| Antigens, CD1d | 1 | 2002 | 6 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 107 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 379 | 0.010 |
Why?
|
| Chile | 1 | 2002 | 6 | 0.010 |
Why?
|
| Argentina | 1 | 2002 | 14 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 990 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 727 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 1516 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 7982 | 0.010 |
Why?
|